日本語 ／ English
NEWS
Announcement of selection for an AMED drug discovery basic technology project for the realization of next-generation treatment and diagnosis entitled “Innovative Next Generation of Oligonucleotide Therapeutics (INGOT)”
Japan Healthcare Venture Summit 2021
Announcement on Completion of signing additional license agreement with Takeda Pharmaceutical Co., Ltd.
Japan Healthcare Venture Summit 2020
Notice of participation in Nippon Shokubai Group
Notice of laboratory relocation
Announcement on Completion of signing license agreement with Ionis Pharmaceuticals, Inc.
Announcement on Completion of signing license agreement with Takeda Pharmaceutical Co., Ltd.
BioJapan2018
Past information
